An update on vaccines for tuberculosis - there is more to it than just waning of BCG efficacy with time.
about
The Immunodominant T-Cell Epitopes of the Mycolyl-Transferases of the Antigen 85 Complex of M. tuberculosisIncreased B and T Cell Responses in M. bovis Bacille Calmette-Guérin Vaccinated Pigs Co-Immunized with Plasmid DNA Encoding a Prototype Tuberculosis AntigenGenetically modified organisms and visceral leishmaniasisDevelopment and initial testing of messages to encourage tuberculosis testing and treatment among Bacille Calmette-Guerin (BCG) vaccinated persons.Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in miceM.tuberculosis mutants lacking oxygenated mycolates show increased immunogenicity and protective efficacy as compared to M. bovis BCG vaccine in an experimental mouse model.ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination.Increasing the Vaccine Potential of Live M. bovis BCG by Coadministration with Plasmid DNA Encoding a Tuberculosis Prototype Antigen.Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety ConsiderationsBiomarkers of tuberculosis: a research roadmap.Timeliness of Childhood Primary Immunization and Risk Factors Related with Delays: Evidence from the 2014 Zhejiang Provincial Vaccination Coverage Survey.Stable, temperature-sensitive recombinant strain of Mycobacterium smegmatis generated through the substitution of a psychrophilic ligA gene.
P2860
Q26852552-78611AA2-E02F-4A2C-8C58-CEAD3ED7C17CQ27302995-31BEF5B5-197D-4A82-9162-578AA1733CF7Q33647026-E7B6D101-7A51-42BC-A905-1FF4D8E1B894Q33668251-859C3754-1377-46D2-99C3-8D5ED6E19DAEQ34722855-D2E08312-1C5F-45E3-A637-1941033ECBD9Q35022769-064B7733-3485-4FCC-AF42-AA798EFAB288Q35069386-B85C22A9-F7B4-4D6B-BA92-6D5AFDE29B36Q35826596-51CAE9CB-4913-433F-A4E2-B86F258A6B0FQ35826779-5B1B5BBC-5E9C-4A18-AB70-700DE9686627Q38111807-D036DA9A-FEB9-41C4-804D-40A934863F2AQ41659397-44248BA6-4F11-4ADF-AD2B-E53CD5BB2E17Q46674683-674F763F-C03A-45AA-A5E1-2990DA0EFAE9
P2860
An update on vaccines for tuberculosis - there is more to it than just waning of BCG efficacy with time.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
An update on vaccines for tube ...... ing of BCG efficacy with time.
@en
type
label
An update on vaccines for tube ...... ing of BCG efficacy with time.
@en
prefLabel
An update on vaccines for tube ...... ing of BCG efficacy with time.
@en
P2860
P1476
An update on vaccines for tube ...... ing of BCG efficacy with time.
@en
P2093
Marta Romano
P2860
P304
P356
10.1517/14712598.2012.721768
P407
P50
P577
2012-09-08T00:00:00Z